Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: No correlation with clinico-pathological characteristics and outcomes
Breast Cancer Research Aug 26, 2017
Curtit E, et al. – The hypothesis that the 94–(single nucleotide polymorphism (SNP)–based risk score was associated with clinico–pathological characteristics, breast cancer subtypes and outcomes in early breast cancer, was examined. This study did not observe any association between a risk score based on 94 SNPs and breast cancer characteristics, cancer subtypes, or patients outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries